We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
+17.55%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$66.8B
AUM Growth
+$2.68B
Cap. Flow
-$6.14B
Cap. Flow %
-9.19%
Top 10 Hldgs %
7.07%
Holding
4,608
New
914
Increased
1,493
Reduced
1,467
Closed
675

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$655M
2
COTY icon
Coty
COTY
+$380M
3
COP icon
ConocoPhillips
COP
+$250M
4
ZBH icon
Zimmer Biomet
ZBH
+$213M
5
VLO icon
Valero Energy
VLO
+$170M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$523M
2
MRK icon
Merck
MRK
+$375M
3
SHPG
Shire pic
SHPG
+$362M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$310M
5
CELG
Celgene Corp
CELG
+$286M

Sector Composition

Rank Sector Weight
1 Healthcare 12.54%
2 Technology 10.66%
3 Financials 10.63%
4 Consumer Discretionary 9.38%
5 Industrials 7.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALSK
3851
DELISTED
Alaska Communications Systems
ALSK
$77K ﹤0.01%
40,258
+16,366
+68% +$29.7K
CRVS icon
3852
Corvus Pharmaceuticals
CRVS
$1.12B
$76K ﹤0.01%
18,830
-41,418
-69% -$175K
ISEE
3853
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$76K ﹤0.01%
+53,766
New +$75.2K
HWCC
3854
DELISTED
Houston Wire & Cable Company
HWCC
$75K ﹤0.01%
+11,799
New +$69.2K
LAC
3855
DELISTED
Lithium Americas Corp. Common Shares
LAC
$74K ﹤0.01%
19,602
-3
-0% -$11
MACK
3856
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$73K ﹤0.01%
13,349
-22,473
-63% -$103K
CEMI
3857
DELISTED
Chembio diagnostics, Inc.
CEMI
$73K ﹤0.01%
+13,089
New +$85K
PGEN icon
3858
Precigen
PGEN
$1.97B
$72K ﹤0.01%
13,707
+1,076
+9% +$7.46K
NETS
3859
DELISTED
Netshoes (Cayman) Limited
NETS
$72K ﹤0.01%
+43,384
New +$90.5K
AENZ
3860
DELISTED
Aenza S.A.A.
AENZ
$70K ﹤0.01%
+6,657
New +$60K
XPL icon
3861
Solitario Resources
XPL
$67.9M
$69K ﹤0.01%
162,356
+3,940
+2% +$1.22K
WTER
3862
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$69K ﹤0.01%
+1,931
New +$93.8K
SRRA
3863
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$67K ﹤0.01%
977
-405
-29% -$26K
CHRA
3864
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$65K ﹤0.01%
+1,021
New +$72.6K
ASLN
3865
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$62K ﹤0.01%
375
-79
-17% -$11.8K
IBRX icon
3866
ImmunityBio
IBRX
$7.3B
$59K ﹤0.01%
37,048
-81,018
-69% -$102K
GER
3867
DELISTED
Goldman Sachs MLP Energy Renaissance Fund
GER
$59K ﹤0.01%
1,182
+8
+0.7% +$388
BRW
3868
Saba Capital Income & Opportunities Fund
BRW
$336M
$51K ﹤0.01%
5,357
-49,545
-90% -$469K
REED
3869
DELISTED
Reeds, Inc. Common Stock
REED
$51K ﹤0.01%
+351
New +$45.9K
SDLP
3870
DELISTED
SEADRILL PARTNERS LLC
SDLP
$49K ﹤0.01%
5,774
+2,557
+79% +$30K
BYFC icon
3871
Broadway Financial
BYFC
$94.3M
$48K ﹤0.01%
4,413
-49
-1% -$517
NEPT
3872
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$48K ﹤0.01%
+11
New +$52.5K
AVP
3873
DELISTED
Avon Products, Inc.
AVP
$47K ﹤0.01%
16,025
-1,310,541
-99% -$3.3M
HLTH
3874
DELISTED
Nobilis Health Corp.
HLTH
$47K ﹤0.01%
134,444
+2,409
+2% +$996
CARM
3875
DELISTED
Carisma Therapeutics
CARM
$46K ﹤0.01%
2,222
-52,773
-96% -$911K

Similar funds

Millennium Management's Q1 2019 Portfolio in Review

As of Q1 2019, Millennium Management held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.

Millennium Management withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Financials.

Against the trend, Millennium Management opened a new position in Zimmer Biomet worth $232M.

  • Millennium Management's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
  • Millennium Management added most to Walt Disney in Q1 2019, an estimated $655M increase.
  • Millennium Management's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
  • Millennium Management fully exited Merck in Q1 2019, selling an estimated $375M.
  • Millennium Management's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
  • Millennium Management opened 914 new positions and closed 675 in Q1 2019.
  • Millennium Management's portfolio value rose 4.2% quarter-over-quarter to $66.8B.

Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.